The Value of Repeated BIOMarker Measurements During an SBT to Predict EXtubation Failure in ICU Patients

NCT05637099 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 266

Last updated 2025-12-16

No results posted yet for this study

Summary

The Value of Repeated BIOMarker Measurements During an SBT to Predict EXtubation Failure in Mechanically Ventilated ICU Patients

Conditions

  • Weaning Failure
  • Mechanical Ventilation
  • Spontaneous Breathing Trial
  • Extubation Failure

Sponsors & Collaborators

  • Roche Diagnostics GmbH

    collaborator INDUSTRY
  • Henrik Endeman

    lead OTHER

Principal Investigators

  • H. Endeman, Dr. · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-05-07
Completion
2026-05-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05637099 on ClinicalTrials.gov